Factors affecting both peripheral blood progenitor cell mobilization and hematopoietic recovery following autologous blood progenitor cell transplantation in multiple myeloma patients: A monocentric study

Leukemia

Volumn 12, Issue 9, 1998, Pages 1447-1456

  Marit, G ^a,b,g   Thiessard, F ^c   Faberes, C ^a   Cony Makhoul, P ^a   Boiron, J M ^a   Bernard, P ^d   Pigneux, A ^a   Puntous, M ^a   Agape, P ^a   Vezon, G ^e   Broustet, A ^a   Girault, D ^f   Salmi, L R ^c   Reiffers, J ^a,b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b CNRS Bordeaux Segalen University   (France)

^c INSERM   (France)

^d HAUT LÉVÊQUE HOSPITAL   (France)

^e Etablissement de Transfus S   (France)

^f Laboratoires Sandoz   (France)

^g BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

Autologous transplantation; Hematopoietic growth factors; High dose cyclophosphamide; Multiple myeloma; Peripheral blood progenitor cell collection

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; IMMUNOSUPPRESSIVE AGENT; MESNA; MUCOLYTIC AGENT;

ADULT; AGED; ARTICLE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL;

EID: 17344363066     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401105     Document Type: Article

References (13)

1. Reiffers J, Marit G, Vezon G, Cony-Makhoul P, Boiron JM, Montastruc M, Rice A, Braustet A. Autologous blood stem cell grafting in hematological malignancies. Present status and future directions. Transfus Sci 1992; 13: 399-405.
2. Marit G, Faberes C, Pico JL, Boiron JM, Bourhis JH, Brault P, Bernard P, Foures C, Cony-Makhoul P, Puntous M, Vezon G, Braustet A, Girault D, Reiffers J. Autologous peripheral blood progenitor cell support following high-dose chemotherapy or chemoradiotherapy in patients with high-risk multiple myeloma. J Clin Oncol 1996; 14: 1306-1313.
3. Barlogie B, Gahrton G. Bone marrow transplantation in multiple myeloma. Bone Marrow Transplant 1991; 7: 71-79.
4. Attal M, Huguet F, Schlaifer D, Payen C, Laroche M, Fournie B, Maziere B, Pris J, Laurent G. Intensive combined therapy for previously untreated aggressive myeloma. Blood 1992; 79: 1130-1136.
5. Fermand JP, Chevret S, Ravaud P, Divine M, Leblond V, Dreyfus F, Mariette X, Brauet JC. High-dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: results of a phase II trial involving 63 patients. Blood 1993; 82: 2005-2009.
6. Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet G, Rossi JF, Casassus P, Thyss A, Maisonneuve H, Facon T, Ifrah N, Payen C, Bataille R. High-dose therapy in multiple myeloma: a prospective randomized study of the Intergroupe Français du Myélome. New Engl J Med 1996; 335: 91-97.
7. Reiffers J, Leverger G, Marit G, Castaigne, S, Tilly H, Lepage E, Henon P, Douay L, Troussard X. Haematopoietic reconstitution after autologous blood stem cell transplantation. In: Gale RP, Champlin R (eds). Bone Marrow Transplantation: Current Controversies. Alan R Liss: New York, 1989, pp 313-320.
8. To LB, Haylock DN, Thorp D, Dyson PC, Branford AL, Ho JQK, Dart CD, Roberts MM. Horwth N, Bardy P, Russell JA, Millar JL, Kimber RJ, Juttner CA. The optimisation of collection of peripheral blood stem cell for autotransplantation in AML. Bone Marrow Transplant 1989; 4: 41-47.
9. Abrams RA, MacCormack K, Bowles C, Deisseroth AB. Cyclophosphamide treatment expands the circulating hematopoietic stem cell pool in dogs. J Clin Invest 1981; 61: 1392-1399.
10. To LB, Shepperd KM, Haylock DN, Dyson PG, Charles P, Thorp D, Dale BM, Dart GW, Roberts MM, Sage RE, Juttner CA. Single high-dose of cyclophosphamide enables the collection of high numbers of hematopoietic stem cells from the peripheral blood. Exp Hematol 1990; 18: 442-447.
11. Smith IE, Evans BD, Harland SJ, Millar JL. Autologous bone marrow transplantation is unnecessary after high-dose cyclophosphamide. Lancet 1983; 1: 76-77 (letter).
12. Lenhard RE, Oken MM, Barnes JM, Humphrey RL, Glick JH, Silverstein N. High-dose cyclophosphamide: an effective treatment for advanced multiple myeloma. Cancer 1984; 53: 1456-1460.
13. Durie BGM, Salmon SE. Multiple myeloma macroglobulinemia and monoclonal gammopathies. In: Hoffbrand AV, Brain MC, Hirsh J (eds). Recent Advances in Haematology. Churchill-Livingstone: New York, 1977, pp 243-261.